LCM
TDOC icon

Lattice Capital Management’s Teladoc Health TDOC Stock Holding History

Lattice Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,020
Closed -$262K – 68
2022
Q1 		$262K Hold
4,020
– – 0.37% 56
2021
Q4 		$369K Buy
+4,020
New +$480K 0.03% 58

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Lattice Capital Management's TDOC Position: Q2 2022 in Review

Lattice Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,020 shares — an estimated $262K sold.

Lattice Capital Management first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $369K in Q4 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Lattice Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Lattice Capital Management sold 4,020 Teladoc Health shares in Q2 2022, an estimated $262K.
  • Lattice Capital Management first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
  • Lattice Capital Management's Teladoc Health position peaked at $369K in Q4 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Lattice Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.